{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:41:21Z","timestamp":1761093681624,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2019\/05722-0","2020\/12842-0","2021\/06138-0","2021\/11606-3","2022\/03316-8","2022\/11038-8","2022\/11039-4"],"award-info":[{"award-number":["2019\/05722-0","2020\/12842-0","2021\/06138-0","2021\/11606-3","2022\/03316-8","2022\/11038-8","2022\/11039-4"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.bcmd.2023.102799","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T06:03:59Z","timestamp":1696831439000},"page":"102799","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Antineoplastic effects of pharmacological inhibitors of aurora kinases in CSF3RT618I-driven cells"],"prefix":"10.1016","volume":"104","author":[{"given":"Nat\u00e1lia Sudan","family":"Parducci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anali Del Milagro Bernabe","family":"Garnique","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keli","family":"Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge Antonio Elias Godoy","family":"Carlos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha Peixoto","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00edvia Bassani Lins","family":"de Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruna Oliveira","family":"de Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo Magalh\u00e3es","family":"Rego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiola","family":"Traina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o Agostinho","family":"Machado-Neto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2023.102799_bb0005","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a008250","article-title":"Hematopoiesis","volume":"4","author":"Rieger","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.bcmd.2023.102799_bb0010","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.cell.2008.01.025","article-title":"Hematopoiesis: an evolving paradigm for stem cell biology","volume":"132","author":"Orkin","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.bcmd.2023.102799_bb0015","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1056\/NEJMra063728","article-title":"The myeloproliferative disorders","volume":"355","author":"Campbell","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2023.102799_bb0020","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2023.102799_bb0025","doi-asserted-by":"crossref","first-page":"20834","DOI":"10.18632\/oncotarget.15355","article-title":"Clinical significance of CSF3R, SRSF2 and SETBP1 mutations in chronic neutrophilic leukemia and chronic myelomonocytic leukemia","volume":"8","author":"Ouyang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bcmd.2023.102799_bb0030","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1038\/leu.2013.122","article-title":"CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia","volume":"27","author":"Pardanani","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2023.102799_bb0035","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa1214514","article-title":"Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML","volume":"368","author":"Maxson","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2023.102799_bb0040","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1016\/j.febslet.2011.04.068","article-title":"Aurora kinase a critically contributes to the resistance to anti-cancer drug cisplatin in JAK2 V617F mutant-induced transformed cells","volume":"585","author":"Sumi","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bcmd.2023.102799_bb0045","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1002\/ijc.28434","article-title":"Bcr-Abl activates AURKA and AURKB in chronic myeloid leukemia cells via AKT signaling","volume":"134","author":"Yang","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bcmd.2023.102799_bb0050","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.bcmd.2023.102799_bb0055","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13008-018-0040-6","article-title":"The functional diversity of Aurora kinases: a comprehensive review","volume":"13","author":"Willems","year":"2018","journal-title":"Cell Div"},{"key":"10.1016\/j.bcmd.2023.102799_bb0060","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12943-020-01305-3","article-title":"Targeting AURKA in cancer: molecular mechanisms and opportunities for cancer therapy","volume":"20","author":"Du","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bcmd.2023.102799_bb0065","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s13277-014-2664-8","article-title":"AZD1152-HQPA induces growth arrest and apoptosis in androgen-dependent prostate cancer cell line (LNCaP) via producing aneugenic micronuclei and polyploidy","volume":"36","author":"Zekri","year":"2015","journal-title":"Tumour Biol."},{"key":"10.1016\/j.bcmd.2023.102799_bb0070","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.leukres.2016.06.011","article-title":"Reversine triggers mitotic catastrophe and apoptosis in K562 cells","volume":"48","author":"Rodrigues Alves","year":"2016","journal-title":"Leuk. Res."},{"key":"10.1016\/j.bcmd.2023.102799_bb0075","doi-asserted-by":"crossref","first-page":"9895","DOI":"10.1038\/s41598-019-46163-2","article-title":"Reversine exhibits antineoplastic activity in JAK2(V617F)-positive myeloproliferative neoplasms","volume":"9","author":"Lima","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcmd.2023.102799_bb0080","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1158\/0008-5472.CAN-08-3203","article-title":"AZD1152 rapidly and negatively affects the growth and survival of human acute myeloid leukemia cells in vitro and in vivo","volume":"69","author":"Oke","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcmd.2023.102799_bb0085","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/CAD.0000000000000563","article-title":"Reversine induces autophagic cell death through the AMP-activated protein kinase pathway in urothelial carcinoma cells","volume":"29","author":"Fang","year":"2018","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.bcmd.2023.102799_bb0090","article-title":"Reversine induced multinucleated cells, cell apoptosis and autophagy in human non-small cell lung cancer cells","volume":"11","author":"Lu","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bcmd.2023.102799_bb0095","doi-asserted-by":"crossref","first-page":"662","DOI":"10.3324\/haematol.12148","article-title":"Effects of the aurora kinase inhibitors AZD1152-HQPA and ZM447439 on growth arrest and polyploidy in acute myeloid leukemia cell lines and primary blasts","volume":"93","author":"Walsby","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2023.102799_bb0100","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/carcin\/bgr278","article-title":"Overcoming CML acquired resistance by specific inhibition of Aurora A kinase in the KCL-22 cell model","volume":"33","author":"Yuan","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bcmd.2023.102799_bb0105","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1478-811X-8-31","article-title":"PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration","volume":"8","author":"Chaitanya","year":"2010","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.bcmd.2023.102799_bb0110","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1093\/nar\/gkn550","article-title":"Gamma-H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin","volume":"36","author":"Kinner","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bcmd.2023.102799_bb0115","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/cdd.2011.96","article-title":"Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012","volume":"19","author":"Galluzzi","year":"2012","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bcmd.2023.102799_bb0120","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1128\/MCB.22.3.874-885.2002","article-title":"Mitotic phosphorylation of histone H3: spatio-temporal regulation by mammalian Aurora kinases","volume":"22","author":"Crosio","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bcmd.2023.102799_bb0125","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.gendis.2020.06.005","article-title":"The Nuclear Factor Kappa B (NF-kB) signaling in cancer development and immune diseases","volume":"8","author":"Zinatizadeh","year":"2021","journal-title":"Genes Dis."},{"key":"10.1016\/j.bcmd.2023.102799_bb0130","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41419-019-1407-6","article-title":"BCL-2 family isoforms in apoptosis and cancer","volume":"10","author":"Warren","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcmd.2023.102799_bb0135","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s13402-020-00551-3","article-title":"Reversine exerts cytotoxic effects through multiple cell death mechanisms in acute lymphoblastic leukemia","volume":"43","author":"Carlos","year":"2020","journal-title":"Cell. Oncol. (Dordr.)"},{"key":"10.1016\/j.bcmd.2023.102799_bb0140","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/CAD.0000000000000523","article-title":"Reactive oxygen species generation and increase in mitochondrial copy number: new insight into the potential mechanism of cytotoxicity induced by aurora kinase inhibitor, AZD1152-HQPA","volume":"28","author":"Zekri","year":"2017","journal-title":"Anti-Cancer Drugs"}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979623000761?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979623000761?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:37:06Z","timestamp":1761050226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979623000761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":28,"alternative-id":["S1079979623000761"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2023.102799","relation":{},"ISSN":["1079-9796"],"issn-type":[{"type":"print","value":"1079-9796"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antineoplastic effects of pharmacological inhibitors of aurora kinases in CSF3RT618I-driven cells","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2023.102799","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102799"}}